Head of Product Management, Mirvie
Biography
Carrie leads Mirvie’s efforts to develop the proprietary Mirvie RNA platform. The platform is first to predict unexpected complications months before symptoms occur by revealing the underlying biology of each pregnancy. It opens a new window into pregnancy health for women to act and their doctors to intervene before unexpected complications become a crisis. Mirvie is shaping the future of pregnancy health by enabling proactive, preventive, and personalized pregnancy care for the well-being of moms and babies. As a board-certified genetic counselor, Carrie’s direct patient care focused on high-risk prenatal care and providing broad access to new diagnostic technologies. She led clinical teams at Massachusetts General Hospital and Sutter Health. Her direct-clinical experience served as the foundation for leading-edge product development at Counsyl, Myriad, and Miroculus.
Talk
Shaping The Future of Pregnancy Health with RNA
1 in 5 pregnancies experience unexpected complications, yet there is no reliable way to detect them. The Mirve RNA platform reveals a fundamental understanding of the underlying biology of each pregnancy, including predicting pregnancy complications months before symptoms occur – a breakthrough enabling earlier and more effective interventions for millions of pregnancies.
Session Abstract – PMWC 2022 Silicon Valley
Track Co-Chairs:
Aleksandar Rajkovic, UCSF
Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health:
- Intro to Women's Health
- Aleksandar Rajkovic, UCSF - US Regulatory/Personalized Medicine and Women's Health
Session Chair: Kathryn G. Schubert, SWHR
- Kaveeta Vasisht, FDA - Reproductive Health
- Hakan Cakmak, UCSF
- Laura Jelliffe-Pawlowski, UCSF - Pregnancy (PANEL)
Session Chair: Yoel Sadovsky, University of Pittsburgh
- Virginia D. Winn, Stanford
- Ananth Karumanchi, Cedars-Sinai Medical Center
- Mira Moufarrej, Stanford University - Carrier Screening: Perspective on the new ACMG Practice Resource
- James D Goldberg, Women's Health Medical Affairs
- Biological Sex Differences in Disease + Inclusion of Women in Clinical Research/Innovation
- Rhonda Voskuhl, UCLA
- Cardiovascular Health
- Nisha Parikh, UCSF
- Jennifer Ann Tremmel, Stanford - Bone Health/Osteoporosis & Menopause
Session Chair: Risa Kagan, UCSF, Sutter Health
- Danit Ariel, Stanford
- Massimiliano (Max) de Zambotti, SRI International - Showcase
- Carrie Haverty, Mirvie
- Kevin P. Rosenblatt, NX Prenatal
- Ripudaman Singh, ARCEDI Biotech
- Claire Tomkins, Future Family
- Donne Russell, Precia Group
- Adam de la Zerda, Visby Medical, Inc.
